GoKawiilCramer flags tech selloff as buying opportunity, calls FedEx holiday upside
On Thursday's CNBC Investing Club 'Morning Meeting,' Jim Cramer said indiscriminate selling following Alphabet's revenue miss and Microsoft's otherwise strong quarter had created buying opportunities in quality tech names. He also discussed Eli Lilly's record-high shares after a strong earnings beat driven by obesity-drug demand, and noted FedEx had raised its full-year earnings outlook despite a softer near-term forecast.
GoKawiil's interpretation of the reporting above, not reported fact.
Cramer's framing suggests some investors may be treating a broad tech pullback as a signal to sell strong and weak companies alike, which he argues misreads individual earnings quality. His comments on Lilly and FedEx point to divergent pockets of strength—pharma demand and holiday shipping—that could offset broader market jitters, though this remains his interpretation rather than confirmed trend data.
- Alphabet and Microsoft reported mixed results, triggering a broader tech selloff despite some underlying strength.
- Eli Lilly hit an all-time high on strong obesity-drug demand and new tolerability treatments in development.
- FedEx raised its full-year earnings outlook but gave a softer fourth-quarter forecast amid rising costs.
Source: cnbc.com — Alexa Lomonaco, 2026-10-29
Published there as: “Cramer sees opportunity amid tech turmoil and predicts a holiday win for FedEx”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.